About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

New to The Street & Sight & Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP

NEW YORK CITY, NEW YORK / ACCESS Newswire / March 14, 2025 / The highly anticipated Visionaries Series from New to The Street and Sight & Sound premieres tomorrow on Bloomberg at 6:30 PM EST as sponsored programming, featuring Acurx Pharmaceuticals. This compelling episode follows the incredible journey of co-founders David P. Luci, Robert J. DeLuccia, and Robert G. Shawah - from their college days to building and exiting successful pharmaceutical companies, and ultimately coming together to launch Acurx Pharmaceuticals.

The series explores the vision, perseverance, and expertise that led them to develop groundbreaking antibiotics, addressing urgent global health challenges with innovative treatments.

About New to The Street

New to The Street is a premier televised business program that has been showcasing innovative companies and industry leaders for over 15 years. Airing as sponsored programming on Fox Business, Bloomberg, and major networks, the show provides national TV exposure, earned media coverage, and strategic outdoor advertising. With over 2.4 million YouTube subscribers, New to The Street delivers compelling content that reaches investors, consumers, and business leaders worldwide.

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. The company's Gram-positive selective spectrum (GPSS®) technology targets DNA polymerase IIIC (pol IIIC), an essential bacterial enzyme, effectively stopping bacterial replication and leading to cell death.

Acurx's lead product candidate, ibezapolstat, is Phase 3 ready for the treatment of Clostridioides difficile (C. difficile) infection, with international clinical trials set to begin this year. The company is also advancing a novel oral antibiotic for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and developing a parallel program for inhaled anthrax treatment.

Meet the Founding Team: From College to Biotech Success

David P. Luci - Co-Founder, President & CEO

David P. Luci began his career in finance and corporate law, before moving into biotech leadership. He co-founded Acurx Pharmaceuticals after serving as President & CEO of Dipexium Pharmaceuticals (Nasdaq:DPRX), where he successfully led its $69 million merger with PLx Pharma Inc. (Nasdaq:PLXP). With a background in healthcare finance at Ernst & Young LLP and corporate law at Paul Hastings LLP, Mr. Luci has been a driving force in biotech innovation and M&A transactions.

Robert J. DeLuccia - Co-Founder, Executive Chairman

Robert J. DeLuccia's executive leadership and marketing expertise have been instrumental in the growth of multiple pharmaceutical companies. Before co-founding Acurx, he was Executive Chairman of Dipexium Pharmaceuticals, leading it through a successful exit. He previously served as CEO of Immunomedics, Inc., President of Sterling Winthrop, and held senior leadership roles at Pfizer. His strategic vision and business development acumen have helped shape Acurx's long-term success.

Robert G. Shawah, CPA - Co-Founder & Chief Financial Officer

Robert G. Shawah is the financial backbone of Acurx Pharmaceuticals. With over 30 years of experience in finance, accounting, and corporate governance, he previously served as Chief Accounting Officer at Dipexium Pharmaceuticals, helping steer the company through its acquisition. His extensive background in financial management and operations includes leadership roles at Arthur Andersen PC and WR Grace & Co.

A Story of Innovation, Grit, and Success

The Visionaries Series offers a rare glimpse into the founding story of Acurx Pharmaceuticals, from college friendships and early career moves to their breakthroughs in biotech and successful pharma exits. The episode highlights how their combined expertise in finance, corporate strategy, and drug development led to the creation of a company poised to revolutionize antibiotic treatments.

Tune in tomorrow at 6:30 PM EST on Bloomberg to watch this exclusive feature on Acurx Pharmaceuticals, airing as sponsored programming!

SOURCE: New To The Street



View the original press release on ACCESS Newswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.